Obstetrics & Gynecology Doctors in Mount Clemens, MI Accepting Medicare

7 Obstetrics & Gynecology doctors found. Showing 1 - 7

Kevin Sorah, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1000 Harrington St, Mount Clemens, MI 48043 Phone: 586-493-8000

Carol Mariam Fischer, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1030 Harrington St, Suite 201, Mount Clemens, MI 48043 Phone: 586-493-3880    Fax: 586-493-3883

Sarah Elise Clayton, DO Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1000 Harrington St, Mount Clemens, MI 48043 Phone: 586-493-3740

Cassandra Nicole Ramar, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1000 Harrington St, Department Of Medical Education, Mount Clemens, MI 48043 Phone: 586-493-8195

Dr. Stacia Dzikunu, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1000 Harrington St, Mount Clemens, MI 48043 Phone: 586-493-8000

Dr. Taylor Weidman, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1000 Harrington St, Mount Clemens, MI 48043 Phone: 586-493-8000

Ramon Enrique Morales Munoz, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1000 Harrington St, Mount Clemens, MI 48043 Phone: 586-493-8000

News Archive

FDA accepts DURECT's New Drug Application for POSIDUR

DURECT Corporation today announced that the New Drug Application for the investigational product POSIDUR (SABER-Bupivacaine) has been accepted by the U.S. Food and Drug Administration indicating that the application is sufficiently complete to permit a substantive review.

New study to reduce racial disparity in dementia

In a new study, one Michigan State University professor will explore why in old age, blacks are much more likely to have dementia than whites.

Mount Sinai launches CombiRx trial to treat relapsing-remitting Multiple Sclerosis

Mount Sinai School of Medicine is the Clinical Coordinating Center for the first study to assess the effectiveness of combining two FDA approved medications as initial treatment for people with Relapsing Remitting Multiple Sclerosis.

Fibrocell Science submits azficel-T final study report to FDA

Fibrocell Science, Inc., a biotechnology company focused on the development of autologous cell therapies for aesthetic, medical and scientific applications, announced today that it has submitted a final study report to the U.S. Food & Drug Administration (FDA) for a completed, six-month histological study examining skin after injections of azficel-T.

Spit and feces test positive for SARS CoV-2 even after recovery

A new study reveals that samples of sputum and feces continue to test positive for the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus even after a person has recovered from COVID-19 and nasopharyngeal secretions test negative for the virus.

Read more Medical News

› Verified 3 days ago